{
    "organizations": [],
    "uuid": "578d8214ecffb9f35b64a5a82c6593d36a489101",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novartis-to-invest-100-mln-over-5/brief-novartis-to-invest-100-mln-over-5-years-in-anti-malarial-drugs-idUSFWN1RU032",
    "ord_in_thread": 0,
    "title": "BRIEF-Novartis to invest $100 Mln over 5 years in anti-malarial drugs",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17 (Reuters) - Novartis AG:\n* NOVARTIS RENEWS COMMITMENT TO MALARIA ELIMINATION, INVESTING USD 100 MILLION TO RESEARCH AND DEVELOP NEXT-GENERATION ANTIMALARIALS Source text for Eikon: Further company coverage: (Reporting by John Miller)\n ",
    "published": "2018-04-17T13:19:00.000+03:00",
    "crawled": "2018-04-18T17:57:05.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "novartis",
        "ag",
        "novartis",
        "renews",
        "commitment",
        "malaria",
        "elimination",
        "investing",
        "usd",
        "million",
        "research",
        "develop",
        "antimalarial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "john",
        "miller"
    ]
}